Hans V. Hogerzeil
- Economics and Econometrics top 1%
- Pediatrics, Perinatology and Child Health top 5%
- Public Health, Environmental and Occupational Health top 5%
- Finance top 5%
- General Health Professions top 10%
- Co-authors
- Jonathan D. QuickMélanie SamsonKatrina PerehudoffEllen ‘t HoenVeronika J. WirtzLembit RägoBrigit ToebesGermán Velásquez
- Topics
- Pharmaceutical Economics and Policy (35 papers)Health Systems, Economic Evaluations, Quality of Life (18 papers)Pharmaceutical studies and practices (10 papers)
- Journals
- New England Journal of MedicineThe LancetSHILAP Revista de lepidopterología
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Hans V. Hogerzeil
62 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 108
- Economics and Econometrics 736
- Pediatrics, Perinatology and Child Health 347
- Public Health, Environmental and Occupational Health 302
- Finance 198
- General Health Professions 186
Countries citing papers authored by Hans V. Hogerzeil
This map shows the geographic impact of Hans V. Hogerzeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans V. Hogerzeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans V. Hogerzeil more than expected).
Fields of papers citing papers by Hans V. Hogerzeil
This network shows the impact of papers produced by Hans V. Hogerzeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans V. Hogerzeil. The network helps show where Hans V. Hogerzeil may publish in the future.
Co-authorship network of co-authors of Hans V. Hogerzeil
This figure shows the co-authorship network connecting the top 25 collaborators of Hans V. Hogerzeil. A scholar is included among the top collaborators of Hans V. Hogerzeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans V. Hogerzeil. Hans V. Hogerzeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 19 | |
| 3 | 20 | |
| 4 | 18 | |
| 5 | 5 | |
| 6 | 8 | |
| 7 | 18 | |
| 8 | 22 | |
| 9 | 18 | |
| 10 | 9 | |
| 11 | 20 | |
| 12 | Essential Medicines in National Constitutions | 1 |
| 13 | Essential Medicines in National Constitutions: Progress Since 2008 | 12 |
| 14 | 15 | |
| 15 | 23 | |
| 16 | Human Rights: A Potentially Powerful Force for Essential Medicines | 1 |
| 17 | 2 | |
| 18 | 137 | |
| 19 | 104 | |
| 20 | 16 |
About Hans V. Hogerzeil
Hans V. Hogerzeil is a scholar working on Economics and Econometrics, Family Practice and Applied Microbiology and Biotechnology, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (35 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Pharmaceutical studies and practices (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (118 citations), Geriatrics and Gerontology (175 citations) and Economics and Econometrics (736 citations). Hans V. Hogerzeil has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Jonathan D. Quick, Mélanie Samson, Katrina Perehudoff, Ellen ‘t Hoen, Veronika J. Wirtz, Lembit Rägo, Brigit Toebes, Germán Velásquez, Zafar Mirza and Godfrey JA Walker. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.